190A — Chordia Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Chordia Therapeutics, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 4,255 | 4,799 | 4,330 | 2,549 |
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 4,482 | 4,892 | 4,605 | 2,669 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 8.16 | 4.42 | 2.74 | 0 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 4,499 | 4,909 | 4,632 | 2,681 |
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 221 | 408 | 471 | 244 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 221 | 408 | 471 | 244 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 4,278 | 4,501 | 4,161 | 2,437 |
| Total Liabilities & Shareholders' Equity | 4,499 | 4,909 | 4,632 | 2,681 |
| Total Common Shares Outstanding |